Announcements Trials
Browse Landscape

Phase

Phase NA 39Phase 2 12Phase 1/2 11Phase 2/3 7Phase 1 7Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 6Recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Breast 1

Conditions

Unresectable Pancreatic Cancer 1Small Cell Lung Carcinoma 1Liver, Cancer of, Non-Resectable 1Colorectal Neoplasms 1Advanced Intestinal Cancer 1Advanced Gastric Cancer 1Advanced Breast Cancer 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Electroporation × Clear all
NCT06185556 2024-08-23

COLDFIRE-III

Amsterdam UMC, location VUmc

Phase 2/3 Recruiting
78 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03239158 2019-01-25

Bioinformation Therapy for Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Liver, Cancer of, Non-Resectable

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Unresectable Pancreatic Cancer

NCT03240224 2019-01-25

Bioinformation Therapy for Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Breast

Advanced Breast Cancer

NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03350490 2019-01-25

Bioinformation Therapy for Intestinal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Advanced Intestinal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡